The American Association for Cancer Research (AACR) has a worrying trend: fewer people are dying from, but cancer rates in young adults are growing. Such findings have prompted urgent appeals for additional research, greater funding and improved treatments.
The Trouble with Young Adults
Lourdes Monje, a 25-year-old from Philadelphia is. Suffering from breast cancer, it had later advanced to her lungs. “I believed I was done for. I figured just one or two years left,” she says. Sadly, stories like Monje’s are not so unique as the numbers continue their climb.
The AACR report shows that understanding why younger people suffer more from cancer requires additional research and funding. As Dr. Patricia LoRusso, AACR president notes, “This issue’s complex nature demands much research to uncover the science that could lead to new therapies. ”
Clinical Trials at the Forefront
Clinical trials are of utmost importance for fighting cancer. Monje has enlisted in one such trial for a new treatment targeting her specific cells. Her hope is that her involvement can benefit others in the future. “The clinical trial isn’t just about me; it helps those who come after me,” she notes.
Source of the Surge?
Research has linked certain lifestyle factors such as heavy alcohol drinking, obesity, and environmental factors to the increase in young adult cancer rates. These high-risk factors along with rising cancer occurrences make early detection and prevention vital.
Positive Leaps for Children and Youth
American Association for Cancer Research’s report also shares promising news, especially regarding child and teen treatments. Customized therapies have bolstered these age groups’ chances for recovery. Over 80% of children with cancer in the U. S. live at least five years past their diagnosis, a marked improvement from years past.
On top of that, deaths from cancer amongst children and teens have seen 24% drop over the recent two decades. This is due to successes with more effective treatments, as well as an increase in FDA certified therapies that target pediatric cancers.
Financial Strains of Cancer Therapy
The financial cost of cancer treatment still presents significant strain. Many young survivors carry a heavy financial burden from their treatment. The AACR reveals that nearly 21% of survivors struggle financially after beat cancer as a child and almost 30% are sent to outstanding bill collections.
These monetary concerns go beyond immediate treatment expenses to even more threatening costs. On average, youth and young adult survivors incur costs up to $259,324 throughout their lifetimes which only adds to an already stressful life.
Urgency for More Research Funding
To tackle these problems, the AACR is advocating for more substantial federal funding for cancer research. They have appealed to Congress to dedicate a minimum of $51.3 billion to the National Institutes of Health (NIH) and $7.93 billion to the National Cancer Institute (NCI) for the 2025 fiscal year. They’re also seeking extra funding for the Centers for Disease Control and Prevention (CDC) and FDA’s Oncology Center of Excellence to ensure thorough cancer prevention, screenings, and faster approval times for fresh treatments.
Dr. LoRusso has warned that with lackluster funding, progress made in recent years could be jeopardized putting patients like Monje on shaky grounds.
Final Thoughts
While progress had been made in cancer outcomes, especially in children and adolescents, young adults’ growing cancer rates highlight the need for better research and creativity in solutions. As the AACR continues to fight for funding and focus on the issue at hand, it is hoped that scientific and medical advancements can present upcoming generations with new life-saving treatments.
